Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro (Q39957730)

15 September 2017

title

Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro (English)

1 reference

15 September 2017

0 references

Jacques Robert

3

0 references

author name string

Stéphane Puyo

series ordinal

1

1 reference

15 September 2017

Valérie Le Morvan

series ordinal

2

1 reference

15 September 2017

publication date

1 January 2008

1 reference

Molecular Diagnosis and Therapy

15 September 2017

published in

1 reference

15 September 2017

volume

12

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

225-234

1 reference

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

A gene expression database for the molecular pharmacology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256288

A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

21 January 2018

1 reference

12 December 2020

Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor receptor expression

1 reference

12 December 2020

Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib

1 reference

12 December 2020

Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma

1 reference

12 December 2020

Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer

1 reference

12 December 2020

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

1 reference

12 December 2020

Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients

1 reference

12 December 2020

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

1 reference

12 December 2020

The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256288

1 reference

15 September 2017

1 reference